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ABSTRACT
Introduction: A subgroup of adolescents and young
adults diagnosed with cancer during adolescence
reports elevated levels of anxiety and depressive
symptoms and unmet needs for psychological support.
Evidence-based psychological treatments tailored for
this population are lacking. This protocol describes a
feasibility study of a guided-internet-administered self-
help programme (YoungCan) primarily targeting
symptoms of anxiety and depression among young
persons diagnosed with cancer during adolescence
and of the planned study procedures for a future
controlled trial.
Methods/analysis: The study is an uncontrolled
feasibility trial with a pre-post and 3-month follow-up
design. Potential participants aged 15–25 years,
diagnosed with cancer during adolescence, will be
identified via the Swedish Childhood Cancer Registry.
30 participants will be included. Participants will
receive YoungCan, a 12-week therapist-guided,
internet-administered self-help programme consisting
primarily of cognitive–behavioural therapy organised
into individually assigned modules targeting depressive
symptoms, worry and anxiety, body dissatisfaction and
post-traumatic stress. Interactive peer support and
psychoeducative functions are also available. Feasibility
outcomes include: recruitment and eligibility criteria;
data collection; attrition; resources needed to complete
the study and programme; safety procedures;
participants’ and therapists’ adherence to the
programme; and participants’ acceptability of the
programme and study methodology. Additionally,
mechanisms of impact will be explored and data
regarding symptoms of anxiety, depression, post-
traumatic stress, body dissatisfaction, reactions to
social interactions, quality of life, axis I diagnoses
according to the Mini International Neuropsychiatric
Interview and healthcare service use will be collected.
Exploratory analyses of changes in targeted outcomes
will be conducted.
Ethics/dissemination: This feasibility protocol was
approved by the Regional Ethical Review Board in
Uppsala, Sweden (ref: 2016/210). Findings will be
disseminated to relevant research, clinical, health
service and patient communities through publications
in peer-reviewed and popular science journals and
presentations at scientific and clinical conferences.
Trial registration number: ISRCTN97835363.
INTRODUCTION
During the past decade, adolescents diag-
nosed with cancer have received increased
Strengths and limitations of this study
▪ This study will examine the feasibility and
acceptability of a guided internet-administered
self-help programme and of the planned proce-
dures to evaluate it using qualitative and quanti-
tative methods.
▪ The main challenges related to the programme
and study procedures will be identified and find-
ings will be used to refine the programme and
design a controlled trial.
▪ Development of the guided self-help programme
has included extensive involvement and consult-
ing of theoretical, clinical and end-user expertise
to ensure its scientific and clinical relevance.
▪ The main study limitations include the uncon-
trolled design, the relatively short follow-up and
the lack of power to examine efficacy.
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attention due to the speciﬁc challenges experienced in
managing the short-term and long-term stressors asso-
ciated with cancer and its treatment while at the same
time transitioning from childhood to adulthood.1 2
Adolescence and emerging adulthood3 are characterised
by rapid physical, social and psychological changes and
include developmental challenges related to independ-
ence, relationships, education and identity. These chal-
lenges are often demanding in themselves and can be
further complicated by the cancer experience.1 Given
the transitions experienced during adolescence and
emerging adulthood, it has been hypothesised that
people diagnosed with cancer during adolescence may
have increased vulnerability to symptoms of anxiety,
depression and post-traumatic stress. Indeed, some
studies have shown that, compared to community con-
trols4 5 and people diagnosed at a younger age,6 7
people diagnosed with cancer during adolescence
report a lower level of health-related quality of life and a
higher level of psychological distress, while others have
not found such differences8 or have even found lower
levels of psychological distress compared to population
norms9 and controls.10 However, across the majority of
studies, a subgroup of adolescent and young adult survi-
vors of cancer during adolescence report symptoms of
anxiety and/or depression at a clinically relevant level.
Importantly, longitudinal studies show that the develop-
ment of cancer-related symptoms is nonlinear, with
people reporting symptoms of anxiety and depression
years after the completion of treatment.11 12
Studies examining the psychological needs experi-
enced by survivors of adolescent cancer are scarce and
those few which have been carried out indicate that the
existing needs are often unmet.13 14 Access to mental
health services and social support, including
peer-to-peer interaction, are some of the most common
unmet needs reported by adolescents and young adults
with cancer.15 Despite the unique challenges and needs
of adolescents and young adults, age-appropriate psycho-
social interventions are lacking.16–18
Given the reports of elevated levels of psychological
distress after completion of treatment for cancer during
adolescence5–7and the lack of evidence-based psycho-
logical interventions,16–18 coupled with difﬁculties in
accessing psychological support services,13–15 there is a
need to increase access to psychological support after
adolescent cancer.4 15 Evidence is accumulating that
internet-based cognitive–behavioural therapy (ICBT) is
effective both clinically and in terms of cost for treat-
ment of depression and anxiety symptomatology in
adults19 and young people20 with effects equivalent to
face-to-face CBT.19 21 ICBT programmes typically
include provision of self-help material via the internet22
but differ with regard to the type and nature of support
provided to engage the patient with the self-help mater-
ial, ranging from self-administered (no speciﬁc support)
to therapist-guided (provision of initial support session
providing a rationale and regular scheduled support
sessions in which progress and process issues are
discussed).23 24
The important advantages of ICBT are that it can be
delivered at a time and place convenient to the individ-
ual and reach people in remote locations25 26 and
thereby increase access to evidence-based treatments.
However, most of the existing ICBT programmes are
developed for mental health populations, and smaller
effect sizes have been shown for people with physical
health conditions than for mental health populations.27
Taken together, there is a need for psychological inter-
ventions addressing the diverse manifestations of illness-
related distress and challenges faced by somatic popula-
tions.28 29 For example, survivors of adolescent cancer
struggle with difﬁculties related to parental overprotec-
tiveness,30 loneliness and isolation,31–33 social inter-
action,34 school difﬁculties and lagging behind,31 33
worry related to potential infertility,34 health anxiety and
fear of recurrence,31 34 35 changes in body appearance
and self-image,31 36 37 and existential thoughts related to
losses and threat to life.34 38 It may be important to
address these difﬁculties when developing psychological
interventions for young people diagnosed with cancer
during adolescence in order to improve acceptability,
engagement and effectiveness.
Although internet-based psychological self-help may
suit the needs of young cancer survivors, only two pub-
lished studies have investigated the feasibility and prelim-
inary clinical efﬁcacy of ICBT for young people
diagnosed with cancer during childhood or adoles-
cence.39–41 One study investigated the feasibility of an
online CBT group intervention to prevent psychosocial
problems among adolescents who had completed treat-
ment for cancer diagnosed during childhood and found
high levels of satisfaction with the intervention among
both participants and the psychologists administering
the intervention.39 Another study examined the feasibil-
ity and preliminary efﬁcacy of an ICBT programme to
reduce symptoms of post-traumatic stress and anxiety
among adolescent and young adult survivors of cancer
during childhood and found the intervention to be
acceptable and efﬁcacious with pre-post medium effect
sizes on post-traumatic stress and anxiety which were sus-
tained at 3-month follow-up.40 41 However, to the best of
our knowledge, no study has evaluated guided ICBT spe-
ciﬁcally developed to reduce symptoms of anxiety and
depression among adolescents and young adults diag-
nosed with cancer during adolescence who have com-
pleted cancer treatment.
The primary aim of the planned study is to investigate
the feasibility of a guided internet-administered self-help
programme (YoungCan) primarily targeting symptoms
of anxiety and depression among young people diag-
nosed with cancer during adolescence, and of the
planned study procedures for a future controlled trial to
evaluate the programme’s clinical efﬁcacy and cost-
effectiveness. The feasibility outcomes concern meth-
odological, procedural and clinical uncertainties,42–44
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and exploratory analyses of changes in targeted out-
comes from baseline to postbaseline assessments will be
conducted.
METHODS
This protocol is informed by the TREND Statement
Checklist45 for reporting non-randomised interventions
and the SPIRIT guidelines46 for reporting clinical trial
protocols.
Design
The study has an uncontrolled, within-group, with a pre-
post and 3-month follow-up design with embedded
mixed-method process evaluation. All participants will
receive a guided internet-administered self-help pro-
gramme lasting 12 weeks. Potential participants will be
identiﬁed via the Swedish Childhood Cancer Registry
(the National Quality Registry, initiated in 1982).
Eligibility criteria
Eligible participants will be aged 15–25 years at study
start; have been diagnosed with cancer when aged
13–18 years; have been treated at a paediatric oncology
unit in Gothenburg, Lund, Linköping or Umeå in
Sweden; have completed successful cancer treatment
(according to the paediatric oncology unit if the
person is 15–17 years at study start or according to self-
report if the person is ≥18 years at study start); be able
to read and write text in Swedish; have access to email,
the internet and a mobile telephone, and report a
need for psychological support. Little data are available
to guide the selection of screening measures for this
population.47 48 As such, no cut-off scores on screening
measures will be used to determine inclusion into the
study; however, the feasibility of screening procedures
will be examined to inform the procedures for a future
controlled trial.
Potential participants will be excluded if they currently
receive psychotherapy or if they display symptoms of
severe depression, active suicidality, psychosis, bipolar
disorder and/or alcohol and/or substance abuse in
immediate need of treatment (based on a clinical assess-
ment combining information from the 9-item Patient
Health Questionnaire (PHQ-9)49 and the Mini-
International Neuropsychiatric Interview (MINI.)50).
People excluded on this basis will be guided to appropri-
ate healthcare.
Sample size
Recent reports recommend sample sizes of 50–60 parti-
cipants51 52 to assess feasibility outcomes and estimate
sample size for a deﬁnitive trial. However, since the
target population in Sweden is very small, coupled with
experiences from other successful feasibility studies53–55
and recommendations,56 we aim to include at least 30
participants in the present study.
Recruitment, setting and procedure
The names and addresses of potential participants will
be identiﬁed via the Swedish Childhood Cancer Registry.
Internet search engines will be used to identify tele-
phone numbers for those aged ≥18 years. For those
aged 15–17 years, telephone numbers will be retrieved
from the paediatric oncology units. Invitations to partici-
pate will be issued in two stages. First, people whose tele-
phone numbers have been identiﬁed will be contacted via
telephone, in alphabetical order, by study personnel and
will receive brief information about the study. Second, if
fewer than 30 people have been included when all people
with identiﬁed telephone numbers have been contacted,
written information about the study will be sent to people
whose telephone numbers have not been identiﬁed or
who have not been reached via telephone. Information
will be posted on social media via patient organisations,
for example, the Swedish Childhood Cancer Foundation
and UngCancer (a non-proﬁt organisation supporting
adolescents and young adults affected by cancer in
Sweden), to raise awareness about the study.
Informed consent and eligibility interview
People who have been contacted via telephone or post
and who are interested in participating will be directed
to a secure website where they can register, provide
informed consent and answer questions regarding symp-
toms of depression (PHQ-949) and Generalized Anxiety
Disorder 7-item scale (GAD-757). Written information
about the study will be sent to caregivers of people aged
15–17 years who have registered on the website.
Potential participants will thereafter be contacted via
telephone by a clinical psychologist for an eligibility
interview to conﬁrm inclusion criteria, that is, com-
pleted successful cancer treatment; able to read and
write text in Swedish; have access to email, the internet
and a mobile telephone; and not currently receiving psy-
chotherapy. The psychologist will also provide a descrip-
tion of the programme, its aims and the types of
problems addressed. Potential participants will be asked
about their own situation and whether they experience
any of the problems addressed in the programme. They
will thereafter decide themselves whether they have a
need for the support provided, with young adults consid-
ered experts of their own perceived needs. Potential par-
ticipants meeting the inclusion criteria and perceiving a
need for psychological support will be interviewed with
the MINI50 to identify people with psychiatric problems
in need of immediate treatment or further examination.
People reporting such problems are excluded and
guided to appropriate healthcare services. If a potential
participant reports suicide ideation but the risk of
suicide is assessed as low, the person is offered participa-
tion and a safety plan is set up collaboratively. People
meeting the eligibility criteria will be offered the oppor-
tunity to participate. If the person is aged 15–17 years,
an assessment of whether he/she understands what par-
ticipation implies will be performed to determine
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whether his/her consent to participate is sufﬁcient or if
it needs to be complemented with caregiver consent. If
the person appears not to understand the implication of
participation, he/she will be asked for permission for
study personnel to collect informed consent from his/
her caregiver(s). If the caregiver(s) does(do) not
consent, participation will not be continued. The ﬂow of
participants through the study is shown in ﬁgure 1.
Self-help programme
Development
Development of the programme was informed by the
UK Medical Research Council (MRC) guidelines for
developing and evaluating complex interventions.44
Research identifying the speciﬁc psychological problems
and needs experienced by young people diagnosed with
cancer during adolescence30–38 and evidence-based cog-
nitive–behavioural models for treating anxiety and
depression58–66 guided development of the programme.
Moreover, development included consultations with
paediatric oncology nurses and mental health staff, psy-
chologists with extensive experience of working with
CBT with adolescent and young adult mental health
populations, psychologists with experience of developing
CBT interventions for chronic illness populations, repre-
sentatives of patient organisations and researchers with
experience of developing and evaluating internet-based
CBT interventions. Communication agencies were con-
sulted to edit the layout of the material and the secure
internet portal—the U-CARE-portal (‘the Portal’)—via
which the programme will be delivered. Teachers with
extensive experience of educating adolescents reviewed
a portion of the text material with regard to readability.
Importantly, a group of adolescents and young adults
with and without lived experience of cancer during ado-
lescence, formed for the purpose of the present project
(n=10), were consulted to review programme content,
layout, readability of text material and the procedures
planned to test the programme. Additional adolescents
and young adults with and without experience of cancer
were consulted during development for input on pro-
gramme content, layout, readability of text material and
procedures planned to evaluate the programme.
Content
Based on descriptions of self-help22 and taxonomies of
level of support,24 the present programme can be
described as guided internet-administered self-help and
includes provision of self-help material via the Portal, an
initial support session via telephone in which individual
problem analyses and idiographic goals are formulated,
and regular guidance from a therapist via telephone and
the Portal to follow participants’ progress and processes.
The programme will be available via the Portal and
consists of ICBT, psychoeducation and interactive peer
support. The ICBT is considered the core of the pro-
gramme and is organised into six chapters: introduction,
depressive symptoms, anxiety and worry, post-traumatic
stress, body dissatisfaction and wrapping up, with the
ﬁrst and last chapters being mandatory. The remaining
chapters are each divided into ﬁve parts and are
assigned to participants based on their needs.
Participant needs are determined by individual problem
analyses combining baseline questionnaires and inter-
view outcomes, a clinical assessment and a collaborative
discussion concerning speciﬁc areas and goals the par-
ticipant would like to prioritise. The clinical assessment
follows the Five Areas Assessment Model,67 based on the
CBT model, providing structure to the assessment.68
The chapter(s) best matching participants’ problem ana-
lyses will be chosen, with additional chapters added later
based on participant need and preference. Participants
will be encouraged to work with one part of a chapter
per week. Each part consists of text material describing
treatment components, homework assignments and
questionnaires in which homework is reported to the
therapist, with text material available as PDF and MP3
ﬁles. The majority of the chapters include a PowerPoint
presentation, which serves to clarify important treatment
principles and help participants make connections
between the material and their own lives. Extensive
efforts have been made to include ‘common factors’ in
the programme and material.69 To develop and maintain
a therapeutic alliance,69 the programme has been devel-
oped to engage participants in the text material by includ-
ing statements of empathy, genuineness and warmth,
narratives referring to struggle and recovery, examples to
help participants relate the text material to their own lives
and personal metaphors for emotional distress.70 Online
supplementary appendix 1 presents an overview of the
ICBT chapters and homework assignments and key refer-
ences used to develop the ICBT content.
Guidance from therapists
Participants will work independently with the pro-
gramme over 12 weeks and receive weekly and at-need
guidance from a therapist via messages within the Portal
or by telephone. How participants would prefer to be
guided is decided collaboratively at study start.
Therapists will provide feedback on homework, reinforce
progress, validate difﬁculties and encourage and guide
continued work with the ICBT following a standardised
treatment manual. Participants will be able to contact
their therapist via the Portal or telephone for additional
guidance, which will be received within one working day.
Given the explorative nature of the study, no maximum
time limit for guidance sessions has been set.
Participants who do not log in or show low activity in the
ICBT will be contacted via text message and/or tele-
phone. During the ﬁrst week of access to the pro-
gramme, participants will be contacted via telephone by
a therapist for an individually tailored individual
problem analysis and formulation of idiographic treat-
ment goals (approximately a 30 min session). On the
basis of this analysis, participants will be recommended
the ICBT chapters that best match their problems.
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Figure 1 CONSORT diagram. GAD-7, Generalized Anxiety Disorder 7-item scale; MINI, Mini-International Neuropsychiatric
Interview; PHQ-9, 9-item Patient Health Questionnaire.
Ander M, et al. BMJ Open 2017;7:e013906. doi:10.1136/bmjopen-2016-013906 5
Open Access
group.bmj.com on April 2, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
Optional support functions
Participants will have access to a number of optional
support functions built into the ICBT programme,
including a library, interaction with other participants
and a Questions and Answers (Q&A) function. The
library consists of written texts, also available as MP3
ﬁles, about common problems and concerns related to
cancer during adolescence, alongside video interviews
with people with lived experience of cancer during ado-
lescence. Further, the programme provides the possibil-
ity to interact with other participants via a chat room, a
discussion forum, a private one-to-one messages func-
tion and a diary function. Interactions are monitored by
study personnel to detect potential risk to self or
inappropriate communication, with participants fully
informed on study entry and when accessing the chat
room for the ﬁrst time. If risk of suicide/self-harm is
detected, standard safety procedures according to the
ethical approval will be followed. Participants will also be
able to pose questions via a Q&A function, receiving an
answer from a study therapist within one working day.
Finally, weekly group chat sessions with a study therapist
will be offered. Each additional support function is
optional and participants do not receive recommenda-
tions regarding optimal level of engagement with these
additional support functions.
Participant adherence
Number of logins, opened ICBT items and completed
homework assignments are continuously logged and
used to assess participants’ adherence to the ICBT.
Number of chat sessions, forum posts, private messages,
diary posts, questions in the Q&A function and visits to
the chat room, forum, diary, library and Q&A functions
are logged to examine feasibility and acceptability of
optional support functions.
Therapist training and adherence
Before study-start, all therapists will take part in a
one-day workshop on the programme by the ﬁrst author
(MA), who was part of the programme development
team. Therapists will receive weekly group clinical super-
vision focusing on case discussions, skills development
and at-need supervision by a licensed psychologist with
experience of working with young people and CBT.
Written communication between participants and thera-
pists will be logged and continuously reviewed by the
clinical supervisor to assess therapists’ adherence to the
ICBT protocol and competence in delivering the ICBT.
A 15% sample of the communication between therapists
and participants within the programme will be reviewed
for therapists’ adherence to the ICBT protocol and com-
petence in delivering the ICBT according to an adher-
ence measure developed for the YoungCan programme.
Findings will be used to identify areas in the programme
and therapists training that require modiﬁcation and/or
further development.
Outcome measurements
Feasibility outcomes
The feasibility outcomes concern methodological, pro-
cedural and clinical uncertainties42–44 related to recruit-
ment and eligibility criteria, data collection, attrition,
resources needed to complete the study and pro-
gramme, safety procedures and process evaluation
including participants’ and therapists’ adherence to the
programme, participants’ acceptability of the pro-
gramme and of the study methodology, and exploration
of mechanisms of impact. A summary of feasibility out-
comes is provided in table 1. In addition, progression
criteria, where applicable, which will be used to deter-
mine whether revisions should be considered before
proceeding to a controlled trial,43 are presented.
Psychological and health economics outcomes
The feasibility of using a number of psychological and
health economics measurements will be examined to
assess whether or not to include them in a controlled
study. The PHQ-949 will be used to measure symptoms of
depression and the GAD-757 to measure anxiety symp-
toms. Body dissatisfaction will be measured with the
Body Image Scale (BIS)71 and post-traumatic stress
symptoms using the Posttraumatic Stress Disorder
Checklist—Civilian version (PCL-C).72 Reactions to
social interaction situations will be measured with the
Social Interaction Anxiety Scale (SIAS).73 The EuroQol
EQ-5D74 will be used to calculate quality-adjusted life
years. Aspects regarding use of healthcare services,
employment, absence and sick leave will be examined
with a modiﬁed short version of the Trimbos and
Institute of Medical Technology Assessment Cost
Questionnaire for Psychiatry (TiC-P),75 assessing direct
and indirect medical costs and indirect non-medical
costs.
Demographics and clinical variables
Data on age, gender, diagnosis and date of ﬁrst diagnosis
will be collected via the Swedish Childhood Cancer
Registry. Self-reported information on education,
employment status (including studying), ethnicity, rela-
tionship status, family situation, housing situation,
cancer recurrence including date, date of end of treat-
ment, type of treatment, presence and type of late
effects and potential receipt of psychological treatment
before and after diagnosis will be collected at baseline.
Data collection
Psychological and health economics-related self-reported
data will be collected at the eligibility interview, the base-
line assessment and the assessments 3 and 6 months
after the baseline assessment. Data will be collected
either via telephone or online via the Portal. Prompts
will be sent via text message and reminders will be sent
via text message or provided by telephone. The outcome
measures and mode of administration, at each assess-
ment, are shown in table 2.
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Data collection via telephone at 3 and 6 months post
baseline will be performed by psychologists and clinical
psychology students not otherwise involved in the study.
Potential participants/participants who report psychi-
atric symptoms in need of treatment or further psychi-
atric examination will be guided to appropriate
healthcare and if the person is aged 15–17 years, their
caregiver(s) will be informed.
Process evaluation
To assess the programme’s relevance in terms of partici-
pants’ acceptability of and adherence to the programme,
Table 1 Feasibility outcomes and progression criteria
Outcome Evaluation
Progression criteria to controlled
trial*
Recruitment and eligibility Number of people identified via the Swedish Childhood
Cancer Registry, invited via telephone, invited via letter,
assessed for eligibility
No criteria set
Percentages of people interested in participation,
assessed for eligibility, meeting the inclusion criteria and
included, of the total number identified
≥15% interested in participating of
the total number identified≥10%
included of the total number
identified
Ambiguities regarding eligibility criteria No criteria set
Numbers scoring above/under recommended cut-offs on
clinical outcome measures
No criteria set
Reasons for ineligibility No criteria set
Reasons for non-participation No criteria set
Data collection Percentage of participants completing assessments 70% answering all questions at all
assessments
Numbers of missing items relating to clinical,
psychological and health economics outcomes
No criteria set
Types and number of potential uncertainties in diagnostic
interviews
No criteria set
Attrition Rates of dropout from study and programme No criteria set
Resources needed to
complete the study and the
programme
Length of time for:
▸ Participants to work through the programme
▸ Participants to complete questionnaires and interviews
▸ Therapists to deliver the programme
▸ Study personnel to administer the study
No criteria set
Safety procedures Ambiguities regarding standard safety procedures
Types and numbers of measures undertaken to assure
patient safety
Types and numbers of unforeseen safety issues
No criteria set
Participants’ adherence to
the ICBT and use of
optional support functions
Number of:
▸ Logins
▸ Opened ICBT items, completed homework
assignments
▸ Chat sessions, forum posts, private messages, diary
posts, questions in the Q&A function
▸ Visits to the chat room, forum, library and Q&A
functions
70% completing the introduction
ICBT chapter, and the first two parts
of an individually assigned chapter
Therapists’ adherence to
programme
Content of online written therapist-participant
communication
No criteria set
Participants’ acceptability
of programme and data
collection and exploration
of mechanisms of impact
Reasons for poor attendance and withdrawal from study
and programme
No criteria set
Impressions and experiences of working with the
programme (including positive and negative
consequences) and of completing questionnaires and
interviews
70% of participants using the
programme reporting that it is
helpful
<1 participant reporting substantial
negative consequences related to
participation in the study and/or
programme
*If one or more criteria are not met, revisions should be considered before proceeding to a controlled trial.
ICBT, internet-based cognitive–behavioural therapy; Q&A, Question and Answer function.
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and to generate hypotheses regarding mechanisms of
impact, semistructured interviews will be conducted via
telephone at baseline and 3 months postbaseline. At
baseline, participants will be asked to describe pro-
blems, hypotheses about problem development and
maintaining factors, experiences of psychological treat-
ment and expectations of the programme. Three
months after baseline, participants will be interviewed
regarding impressions and experiences of working with
the programme and of completing questionnaires and
interviews. Moreover, participants’ activity in the Portal
will be logged continuously to assess adherence to the
ICBT and the feasibility and acceptability of optional
support functions. Non-attendees, that is, those included
but who do not attend the ﬁrst week telephone session or
complete the ICBT introduction chapter and poor atten-
dees, that is, those included who attend the ﬁrst week tele-
phone assessment and complete the ICBT introduction
chapter but fail to complete more than the ﬁrst part of
the assigned ICBT chapter, will be asked about their
reasons for not adhering to the programme and what a
programme should include. To explore non-acceptability
of the programme and methods, participants who choose
to exit the study will be asked if they agree to be inter-
viewed about their reasons for exiting and what a pro-
gramme should include. Interviews will be conducted via
telephone by clinical psychology students not involved in
delivering the programme and are anticipated to last
∼45 min. If the participant permits, the interview will be
digitally recorded. Participants will be given the option to
complete the interview over one or two telephone
sessions.
Data analyses
Data analyses will primarily be descriptive and will
address the primary outcomes relating to the feasibility
of the programme and study methods.
Quantitative analyses
The CONSORT diagram will be used to illustrate partici-
pant ﬂow. Numbers of potential participants identiﬁed
via the Swedish Childhood Cancer Registry, invited via
telephone, invited via letter, assessed for eligibility, eli-
gible and included will be reported. The percentages
of potential participants willing to undergo eligibility
assessment of the total number invited, of potential
participants overall meeting the eligibility criteria out of
the total number invited and of participants overall
enrolled in the study out of the total number invited
will be calculated with exact 95% CIs. Reasons for ineli-
gibility, ambiguities regarding eligibility criteria, reasons
for non-participation and numbers included via tele-
phone versus postal letter will be reported. To generate
hypotheses regarding appropriate screening measures,
numbers scoring above/under cut-offs recommended
for similar populations on clinical outcome measures
related to problems addressed in the ICBT will be
reported.
Follow-up rates and numbers of missing items relating
to clinical outcomes will be calculated with 95% CIs
alongside means and SDs for the number of reminders
via text message and telephone. Potential assessment
uncertainties in diagnostic interviews will be reported
alongside means and SDs for time taken to complete
questionnaires and interviews. Descriptive statistics includ-
ing the means and SDs or medians and IQRs and change
scores for each outcome measurement at the eligibility
interview, baseline and 3 and 6 months postbaseline will
be reported. Attrition proportions (both programme and
study dropout) will be reported with 95% CIs.
Means, SDs and frequencies for each Portal activity
relating to adherence to the ICBT including logins;
opened ICBT items and completed homework assign-
ments will be reported; alongside means, SDs and fre-
quencies for each Portal activity relating to the use of
optional support functions including chat sessions;
Table 2 Outcome measures at each assessment
Measure
Eligibility
interview
Baseline
assessment
Assessment at
3 months
postbaseline
Assessment at
6 months
postbaseline
Mode of
administration
Demographics and clinical
variables
x Online
PHQ-9 x x x Online
GAD-7 x x x Online
BIS x x x Online
PCL-C x x x Online
SIAS x x x Online
EQ-5D x x x Online
Modified TiC-P x x x Online
MINI x x x Telephone
BIS, Body Image Scale; EQ-5D, EuroQol 5-dimension questionnaire; GAD-7, Generalized Anxiety Disorder 7-item scale; MINI, Mini-
International Neuropsychiatric Interview; PHQ-9, 9-item Patient Health Questionnaire; PCL-C, Posttraumatic Stress Disorder Checklist-Civilian
version; SIAS, Social Interaction Anxiety Scale; TiC-P, Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for
Psychiatry.
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forum posts; private messages; diary posts; questions in
the Q&A function; visits to the chat room, forum, diary
and Q&A functions, and visits to the library will be
reported. Means, SDs and frequencies of participant–
therapist contact within the Portal and via telephone will
be reported and therapist adherence measures will be
summarised with means and SDs and collated in total
and by therapist.
Means and SDs for the length of time taken for parti-
cipants to work through the programme; for participants
to complete the eligibility assessment, baseline, follow-up
assessments and interviews; for therapists to deliver the
programme; for therapist training and supervision, and
for project personnel to administer the data collection
procedures from the invitation to the 3-month follow-up,
will be reported to estimate the required resources and
to assess the feasibility of the programme and suggested
methods. Finally, potential ambiguities regarding stand-
ard safety procedures, types and numbers of measures
undertaken to assure patient safety and types and
numbers of unforeseen safety issues will be reported.
Qualitative analyses
Answers to semistructured questions will be recorded,
transcribed verbatim, checked for accuracy by the ﬁrst
author (MA) and thereafter analysed with manifest
content analysis.76 The same analysis will be used to
analyse the communication in the interactive functions
of the programme. Two researchers will be involved in
all stages of the analysis to enable reﬂection and discus-
sion during the entire process.76 Tentative categories
and subcategories will be presented to an additional
researcher and people with lived experience of cancer
during adolescence to discuss the credibility of how data
have been sorted. The necessary revisions will be made
and thereafter categories and subcategories will be pre-
sented to study participants to explore whether the cat-
egorisation and labelling of data accurately illustrates
participants’ experiences.
ETHICS AND DISSEMINATION
The study will be conducted in accordance with the
Helsinki Declaration to ensure the welfare and rights of
participants. The participants’ conﬁdentiality will be
guaranteed and consideration will be given to their
integrity, dignity and vulnerability. Informed consent will
be collected to ensure that participants are aware of the
conditions of participation. Participants exiting the study
will be reminded about their rights to exit without
giving any reasons. All data will be handled in accord-
ance with the Swedish Personal Data Act (1998:204) and
Patient Data Act (2008:355). Potential participants will be
assigned a user ID to de-identify data. Data not collected
via the Portal will be stored in a locked ﬁling cabinet, only
accessible to the researchers, with participant personal
information stored separately from de-identiﬁed data. All
data collected via the Portal will be stored on secure
servers at Uppsala University. Personal data and user gen-
erated data are stored in different databases on different
servers. The Portal secures de-identiﬁcation of data and
prevents unauthorised persons from connecting data
from different Portal databases.
Potential adverse events and negative effects of the
programme and study will be explored and reported.
Assessments of whether participants present symptoms
requiring psychological services that cannot be offered
within the scope of this study will be made at three
assessments. Moreover, online written communication
will be monitored to detect participants who signal a
need for more extensive services, including risk of harm
to self, and with the management of potentially harmful
or destructive online communication. Standard safety
procedures for managing such instances have been
developed, with participants fully informed of these pro-
cedures on study entry. People with a need for psycho-
logical services that cannot be met within this study will
be guided to appropriate healthcare services.
DISCUSSION
Evidence-based interventions to reduce psychological dis-
tress following cancer during adolescence are lacking
and the psychological needs of survivors of adolescent
cancer are often unmet.13 14 Adolescents and young
adults diagnosed with cancer during adolescence are a
relatively small and geographically dispersed group, and
ICBT may have the potential to overcome many of the
barriers to psychological support that have been reported
by this population.77 However, evidence indicates that to
be effective, ICBT programmes may need to address the
unique experiences of people with physical health condi-
tions and comorbid anxiety and depression.28 This study
will test the feasibility of YoungCan, an internet-based
self-help programme developed to reduce anxiety and
depressive symptoms among young people diagnosed
with cancer during adolescence. Testing the feasibility of
complex interventions and trial methods is strongly
recommended to estimate important parameters and
answer key uncertainties required to design controlled
trials.40 41 Given the novelty of the programme and the
few intervention studies conducted with the target popu-
lation, assessing the acceptability and feasibility of the
programme and methods used is of great importance in
guiding programme reﬁnements and informing the
planning of an efﬁcacy trial, including the generation of
hypotheses regarding mechanisms of impact.
If the programme proves feasible, our aim is to evalu-
ate it in a controlled trial, and if it proves effective we
will aim to implement the programme within routine
follow-up care of young persons treated for cancer
during adolescence. Guided internet-administered self-
help tailored to young people diagnosed with cancer
during adolescence has the potential to decrease suffer-
ing and costs for the individual as well as costs for
society as a whole.
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